Products
Lyfegen Agreements Library
Lyfegen Rebate Analytics Platform
Product Name
Product Name
Product Name
Product Name
Case Studies
Careers
Blog
The Lyfegen Models & Agreement Library
New
Global
Launch
Agreement & Refund Analytics
The Lyfegen Models & Agreement Library
Start Your Free Trial
Login
Beautiful banking to grow smarter
Powerful, self-serve product and growth analytics to help you convert, engage, and retain more users. Trusted by over 4,000 startups.
Talk to sales
The latest news from Lyfegen...
This is some text inside of a div block.
This is some text inside of a div block.
Empowering Customers with Passion and Expertise: Meet Cedric Sidler, Lyfegen's Newest Customer Success Specialist
Conozca a David Duro, nuestro nuevo Vicepresidente de Ventas y Desarrollo de Negocio - Un líder que conecta con sus clientes y les ofrece soluciones eficaces
May 16, 2023
Meet David Duro, Our New VP of Sales & Business Development - A Leader Who Connects with his Customers and Helps Them Find Powerful Solutions
May 16, 2023
Meet Olga Dragos, Our Newest Key Member and Efficiency Champion
April 27, 2023
Exclusive interview with Girisha Fernando at the launch of Lyfegen’s Value-Based Agreement Library
April 20, 2023
Lyfegen Launches the World's Largest Database of Value-Based Drug Agreements
March 29, 2023
Envisioning solutions that solve meaningful real-world problems – meet Andrei Cantea, our new visionary Senior Product Designer
April 6, 2023
A big win for value-based care: Medicare can now negotiate some drug prices
November 10, 2022
Medicare Part D redesign could reboot U.S. prescription drug market for cancer drugs, making pricing more value-based
October 28, 2022
Lyfegen and Switzerland’s EGK Insurance Partner to Reduce Prices for High-cost Drugs
November 28, 2022
All
Team
Editorial
Investor
Meet David Duro, Our New VP of Sales & Business Development - A Leader Who Connects with his Customers and Helps Them Find Powerful Solutions
May 16, 2023
Meet Olga Dragos, Our Newest Key Member and Efficiency Champion
April 27, 2023
Exclusive interview with Girisha Fernando at the launch of Lyfegen’s Value-Based Agreement Library
April 20, 2023
Envisioning solutions that solve meaningful real-world problems – meet Andrei Cantea, our new visionary Senior Product Designer
April 6, 2023
Lyfegen Launches the World's Largest Database of Value-Based Drug Agreements
March 29, 2023
Lyfegen and Switzerland’s EGK Insurance Partner to Reduce Prices for High-cost Drugs
November 28, 2022
A big win for value-based care: Medicare can now negotiate some drug prices
November 10, 2022
Medicare Part D redesign could reboot U.S. prescription drug market for cancer drugs, making pricing more value-based
October 28, 2022
Meet our new in-house detective: Hello to Alina Bratu!
October 26, 2022
Value-based drug agreements are easier when drug manufacturers and payers follow FDA communication guidelines
October 13, 2022
Federal Trade Commission inquiry could eventually lead to overhaul of prescription drug rebate system
September 29, 2022
Lyfegen Raises $8 Million to Drive Down Drug Costs and Help Patients Access Life-Saving Medications
September 20, 2022
After accelerated drug approval: Value-based drug pricing does the work of real-world data collection
September 16, 2022
The uphill battle for value-based drug pricing agreements may be coming to an end
August 29, 2022
Leveraging clinical- and cost-effectiveness data to inform drug pricing and reimbursement
August 24, 2022
Keeping our users happy everyday: Meet Liubov, our new quality assurance (QA) engineer
August 18, 2022
Indication-specific pricing to make inroads in the U.S.
August 4, 2022
Value-based pricing vs best price? Medicaid's best price problem
July 27, 2022
Biosimilars appear ready for prime time in the U.S. as reimbursement is increasingly value-based
July 21, 2022
How to overcome hurdles to implement value-based pricing
July 13, 2022
Hello to our new team member: Meet efficacy expert Anca Marin!
July 5, 2022
Who does it better? Assessing a value-based drug price in Europe vs the US
June 30, 2022
Could a value-based purchasing agreement with the U.S. Centers for Medicaid and Medicare Services have saved Aduhelm?
June 22, 2022
A new star in the Lyfegen sky: Meet Valeria Litfullina, our new front-end developer
June 16, 2022
Healthcare providers hold real-world evidence about a drug’s value. How to convince them to share the data?
June 9, 2022
U.S. Department of Health and Human Services’ Innovation Center Revamps Value-Based Payment Models
May 18, 2022
Do drug companies really want more competition? Value-based purchasing puts them to the test
May 11, 2022
Is this new drug worth the cost? Payers decide using value-based purchasing agreements
May 3, 2022
Changes in Medicaid’s Best Price Rule Likely to Boost Value-Based Purchasing Agreements
April 22, 2022
Industry experts agree outcome-based contracting is vital to the future of cell and gene therapies
April 14, 2022
Medicare needs authority to negotiate drug prices to support its value-based healthcare strategy
April 4, 2022
The Tech Team Keeps Growing! Welcome to the Lyfegen Team, Analytical-Superstar, Pavlo!
March 16, 2022
ICER: Hero or Villain in the Story of Value-Based Drug Pricing?
March 2, 2022
Bluebird Bio’s exiting the European market signals problems for cell and gene therapy market access
February 22, 2022
The Effect of Value-Based Drug Pricing on Patient Health Outcomes: More of what’s needed—Efficacy, Access, and Affordability
February 14, 2022
Former New York State Medicaid Director Jason Helgerson joins Lyfegen advisory board
November 10, 2021
CMA & Lyfegen Present Joint Value-Based Contracting Platform for Pharmacy at Medicaid’s Most Important Conference
November 8, 2021
Swiss health insurance Sympany implements Lyfegen Platform to efficiently execute complex value & data-driven agreements for high-priced medication.
October 26, 2021
The importance of working with Johnson & Johnson: An interview with our Lyfegen CEO & Founder, Girisha Fernando
September 22, 2021
How Far Would You go to Save Your Child?
September 6, 2021
How Lyfegen’s value-based contracting platform was inspired by Airbnb
August 20, 2021
A new face is on board! Welcome to Lyfegen, Tech-Guru Andrei
August 10, 2021
Breaking News: Lyfegen platform supports Johnson & Johnson to further drive value-based healthcare strategy
July 29, 2021
Our team is growing! Welcome to Lyfegen, Tech-Genius Giancarlo!
July 19, 2021
Nico Mros named Lyfegen’s Chief Customer Experience Officer (CXO)
April 21, 2021
Welcome to the Lyfegen Team, Mastermind-Developer, Thungu!
April 14, 2021
Welcome to the Lyfegen Team, Design-Superstar, Kateryna!
March 15, 2021
2021 brings great news as Lyfegen’s team continues to grow: Antti joins as Product Owner!
January 4, 2021
Lyfegen welcomes Frederico as Chief Technology Officer!
December 2, 2020
The tech team is growing at full-speed! Welcome to the Lyfegen team, tech-genius Dima!
November 11, 2020
At the forefront of value-based healthcare: Lyfegen and KPMG Switzerland release whitepaper together
October 26, 2020
The Tech Team Keeps Growing! Welcome to the Lyfegen Team, Analytical-Superstar, Pavlo!
October 8, 2020
Lyfegen Supports the Sustainable Development Goal #3: Good Health & Well Being
October 6, 2020
Lyfegen selected to join Groupe Mutuel’s acceleration program InnoPeaks!
September 21, 2020
Lyfegen is at the World Pharma Pricing, Evidence & Market Access Congress!
September 15, 2020
Our new tech superstar: Welcome to the Lyfegen team, Daniel!
September 11, 2020
Breaking News: Lyfegen Raises Additional CHF 2 Million to Advance Value-Based Healthcare Contracting
September 1, 2020
As Costs Continue to Rise, An Era of Change in the Swiss Healthcare System Approaches
August 21, 2020
Michael Porter’s VBHC Theory Explained by Lyfegen’s Customer Success Hero, Simon Amstutz
August 13, 2020
What does “Mindful Leadership” Mean for the CEO of a Health Tech Start-up – During a Pandemic Era?
August 6, 2020
Hopp Schwiiz: Switzerland leading Innovation in Europe
July 31, 2020
Trump's four executive orders to lower drug prices: what does this mean for value-based contracting & innovative drugs?
July 28, 2020
Corina Sommer, joins Lyfegen Advisory Board
July 22, 2020
Our new Customer Success Hero: Welcome to the Lyfegen team, Simon Amstutz!
July 14, 2020
At Lyfegen, the security of patient data is of utmost importance! We are proud to announce that we are ISO 27001 certified, an internationally recognised information security standard!
July 9, 2020
João Marques-Gomes, PhD, joins Lyfegen Advisory Board
June 25, 2020
At Lyfegen customers are at the centre of our heart! We are proud to announce that we are ISO 9001:2015 certified!
June 17, 2020
What is value-based contracting with Lyfegen?
May 29, 2020
Join Lyfegen's CFO, Michel Mohler, on June 18th at the Basel Area Business & Innovation and Deloitte «DayOne Experts» webinar!
May 29, 2020
Find us in the first Startup Guide for Switzerland! We were selected as one of the most innovative startups with a clear vision for impact on people and the planet.
May 29, 2020
Have you voted yet? Vote now for Lyfegen as Swiss Startup 2020!
May 29, 2020
Professor Jens Grüger, PhD, joins Lyfegen Advisory Board
July 28, 2019
Melya Hughes Crameri, PhD joins Lyfegen Advisory Board
May 31, 2019
Lyfegen raises CHF 750‘000 in Seed Capital
April 17, 2019
Empowering Customers with Passion and Expertise: Meet Cedric Sidler, Lyfegen's Newest Customer Success Specialist
Empowering Customers with Passion and Expertise: Meet Cedric Sidler, Lyfegen's Newest Customer Success Specialist
Conozca a David Duro, nuestro nuevo Vicepresidente de Ventas y Desarrollo de Negocio - Un líder que conecta con sus clientes y les ofrece soluciones eficaces
May 16, 2023
Meet David Duro, Our New VP of Sales & Business Development - A Leader Who Connects with his Customers and Helps Them Find Powerful Solutions
May 16, 2023
Meet Olga Dragos, Our Newest Key Member and Efficiency Champion
April 27, 2023
Envisioning solutions that solve meaningful real-world problems – meet Andrei Cantea, our new visionary Senior Product Designer
April 6, 2023
Meet our new in-house detective: Hello to Alina Bratu!
October 26, 2022
Keeping our users happy everyday: Meet Liubov, our new quality assurance (QA) engineer
August 18, 2022
Hello to our new team member: Meet efficacy expert Anca Marin!
July 5, 2022
A new star in the Lyfegen sky: Meet Valeria Litfullina, our new front-end developer
June 16, 2022
Former New York State Medicaid Director Jason Helgerson joins Lyfegen advisory board
November 10, 2021
Exclusive interview with Girisha Fernando at the launch of Lyfegen’s Value-Based Agreement Library
April 20, 2023
Lyfegen Launches the World's Largest Database of Value-Based Drug Agreements
March 29, 2023
A big win for value-based care: Medicare can now negotiate some drug prices
November 10, 2022
Medicare Part D redesign could reboot U.S. prescription drug market for cancer drugs, making pricing more value-based
October 28, 2022
Lyfegen and Switzerland’s EGK Insurance Partner to Reduce Prices for High-cost Drugs
November 28, 2022
Value-based drug agreements are easier when drug manufacturers and payers follow FDA communication guidelines
October 13, 2022
The uphill battle for value-based drug pricing agreements may be coming to an end
August 29, 2022
How to overcome hurdles to implement value-based pricing
July 13, 2022
Who does it better? Assessing a value-based drug price in Europe vs the US
June 30, 2022
Value-based pricing vs best price? Medicaid's best price problem
July 27, 2022
Next
Federal Trade Commission inquiry could eventually lead to overhaul of prescription drug rebate system
September 29, 2022
Lyfegen Raises $8 Million to Drive Down Drug Costs and Help Patients Access Life-Saving Medications
September 20, 2022
After accelerated drug approval: Value-based drug pricing does the work of real-world data collection
September 16, 2022
Leveraging clinical- and cost-effectiveness data to inform drug pricing and reimbursement
August 24, 2022
Indication-specific pricing to make inroads in the U.S.
August 4, 2022
Bluebird Bio’s exiting the European market signals problems for cell and gene therapy market access
February 22, 2022
Lyfegen raises CHF 750‘000 in Seed Capital
April 17, 2019
By clicking
“Accept All Cookies”
, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Deny
Accept